Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Stegmeier

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Genes & Development|July 3, 2010
The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosomeEun Joo Song, Shannon L Werner, Jakob Neubauer, et al.
Cancer Research|March 20, 2015
A chemical genetics approach for the functional assessment of novel cancer genesQianhe Zhou, Adnan Derti, David Ruddy, et al.
Nature Cell Biology|April 10, 2007
A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signallingViji M Draviam, Frank Stegmeier, Grzegorz Nalepa, et al.
Cancer Research|October 23, 2015
Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung CancerAlexandra B Lantermann, Dongshu Chen, Kaitlin McCutcheon, et al.
Cancer Research|February 18, 2011
Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomasTara L Naylor, Huaping Tang, Boris A Ratsch, et al.
Oncotarget|April 26, 2013
Targeting HSF1 sensitizes cancer cells to HSP90 inhibitionYaoyu Chen, Jinyun Chen, Alice Loo, et al.
Nature|April 20, 2007
Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activitiesFrank Stegmeier, Michael Rape, Viji M Draviam, et al.
Cancer Discovery|July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)Manav Korpal, Joshua M Korn, Xueliang Gao, et al.
Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.
Elife|May 22, 2014
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cellsYubao Wang, Young-Mi Lee, Lukas Baitsch, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Genes & Development|July 3, 2010
The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosomeEun Joo Song, Shannon L Werner, Jakob Neubauer, et al.
Cancer Research|March 20, 2015
A chemical genetics approach for the functional assessment of novel cancer genesQianhe Zhou, Adnan Derti, David Ruddy, et al.
Nature Cell Biology|April 10, 2007
A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signallingViji M Draviam, Frank Stegmeier, Grzegorz Nalepa, et al.
Cancer Research|October 23, 2015
Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung CancerAlexandra B Lantermann, Dongshu Chen, Kaitlin McCutcheon, et al.
Cancer Research|February 18, 2011
Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomasTara L Naylor, Huaping Tang, Boris A Ratsch, et al.
Oncotarget|April 26, 2013
Targeting HSF1 sensitizes cancer cells to HSP90 inhibitionYaoyu Chen, Jinyun Chen, Alice Loo, et al.
Nature|April 20, 2007
Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activitiesFrank Stegmeier, Michael Rape, Viji M Draviam, et al.
Cancer Discovery|July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)Manav Korpal, Joshua M Korn, Xueliang Gao, et al.
Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.
Elife|May 22, 2014
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cellsYubao Wang, Young-Mi Lee, Lukas Baitsch, et al.
Pageof 4